Order Now, Ships Today
$250.00
One-time
These products are for laboratory research only and not intended for medical use. They are not FDA-approved to diagnose, treat, cure, or prevent any disease. By purchasing, you certify they will be used solely for research and not for human or animal consumption.
Quality controlled from start to finish.
No outsourcing.
“Reta” is the shortened name for the newest, next-generation GLP-1/GIP/glucagon receptor agonist designed to help with weight management and metabolic health. It is a novel, synthetic peptide designed to target the GLP-1 receptor for the treatment of obesity and related metabolic disorders. This innovative peptide has been engineered to exhibit enhanced stability, prolonged half-life, and improved potency compared to native GLP-1. Reta has shown promising results in preclinical studies, demonstrating significant weight loss, improved glucose homeostasis, and reduced inflammation. As a potential therapeutic agent, Reta offers hope for individuals struggling with obesity and its associated comorbidities, providing a targeted approach to managing metabolic health. Requires reconstitution before use.
